Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice

Jaeschke, 2003, Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning, Am J Physiol Gastrointest Liver Physiol, 284, G15, 10.1152/ajpgi.00342.2002 Teoh, 2003, Hepatic ischaemia reperfusion injury. Pathogenic mechanisms and basis for protection, J Gastroenterol Hepatol, 18, 891, 10.1046/j.1440-1746.2003.03056.x Jaeschke, 1990, Neutrophils contribute to ischemia-reperfusion injury in rat liver in vivo, Fed Am Soc Exp Biol J, 4, 3355 Jaeschke, 1993, Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia, Am J Physiol Gastrointest Liver Physiol, 264, G801, 10.1152/ajpgi.1993.264.4.G801 Colletti, 1990, Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat, J Clin Invest, 85, 1936, 10.1172/JCI114656 Rudiger, 2002, Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver, Gastroenterology, 122, 202, 10.1053/gast.2002.30304 Teoh, 2003, Low dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning, Hepatology, 37, 118, 10.1053/jhep.2003.50009 Teoh, 2004, Dual role of tumor necrosis factor-α in hepatic ischemia reperfusion injury: studies in tumor necrosis factor-α gene knockout mice, Hepatology, 39, 412, 10.1002/hep.20035 Peralta, 1999, Protective effect of liver preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat, Hepatology, 30, 1481, 10.1002/hep.510300622 Clavien, 2000, Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans, Ann Surg, 232, 163, 10.1097/00000658-200008000-00001 Teoh, 2002, Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase and cell cycle entry, Hepatology, 36, 94, 10.1053/jhep.2002.33134 Clavien, 2003, A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning, Ann Surg, 238, 843, 10.1097/01.sla.0000098620.27623.7d Brenner, 1998, Signal transduction during liver regeneration, J Gastroenterol Hepatol, 13, S93, 10.1111/jgh.1998.13.s1.93 Fausto, 2000, Liver regeneration, J Hepatol, 32, 19, 10.1016/S0168-8278(00)80412-2 Yamada, 1997, Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor, Proc Natl Acad Sci USA, 94, 1441, 10.1073/pnas.94.4.1441 Webber, 1998, Tumor necrosis factor primes hepatocytes for DNA replication in the rat, Hepatology, 28, 1226, 10.1002/hep.510280509 Xu, 1998, Glutathione modulates rat and mouse hepatocyte sensitivity to tumour necrosis factor α toxicity, Gastroenterology, 115, 1229, 10.1016/S0016-5085(98)70095-2 Cressman, 1994, Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver, J Biol Chem, 269, 30429, 10.1016/S0021-9258(18)43831-8 Fitzgerald, 1995, Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration, Cell Growth Differ, 6, 417 Cressman, 1996, Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice, Science, 274, 1379, 10.1126/science.274.5291.1379 Yamada, 1998, Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor, Hepatology, 28, 959, 10.1002/hep.510280410 Selzner, 2002, Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: a TNF-alpha/IL-6 -dependent mechanism, Hepatology, 36, 812, 10.1053/jhep.2002.35535 Camargo, 1997, Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent, Hepatology, 26, 1513, 10.1002/hep.510260619 Selzner, 1999, Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6, Hepatology, 30, 469, 10.1002/hep.510300215 Sun, 2003, In vitro interleukin-6 prevents mortality associated with fatty liver transplants in rats, Gastroenterology, 125, 202, 10.1016/S0016-5085(03)00696-6 Hong, 2004, Interleukin-6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease, Hepatology, 40, 933, 10.1002/hep.20400 Essani, 1996, Endotoxin-induced activation of nuclear factor transcription factor-κB and expression of E-selectin messenger RNA in hepatocytes, kupffer cells, and endothelial cells in vivo, J Immunology, 156, 2956, 10.4049/jimmunol.156.8.2956 Blindenbacher, 2003, Interleukin-6 is important for survival after partial hepatectomy in mice, Hepatology, 38, 674, 10.1053/jhep.2003.50378 Wuestefeld, 2003, Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration, J Biol Chem, 278, 11281, 10.1074/jbc.M208470200 Guidi, 2003, Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans, Dig Liver Dis, 35, 409, 10.1016/S1590-8658(03)00156-7 Cressman, 1995, Rapid activation of the STAT3 transcription factor complex in liver regeneration, Hepatology, 21, 1443, 10.1002/hep.1840210531 Serafin, 2004, Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion, Hepatology, 39, 688, 10.1002/hep.20089 Taub, 2003, Hepatoprotection via the IL-6/STAT3 pathway, J Clin Invest, 112, 978, 10.1172/JCI19974 Hirano, 2000, Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors, Oncogene, 19, 2548, 10.1038/sj.onc.1203551 Vajdova, 2004, Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and kupffer cell function after ischemic injury, Liver Transpl, 10, 520, 10.1002/lt.20126 Debonera, 2001, Activation of interleukin-6/STAT3 and liver regeneration following transplantation, J Surg Res, 96, 289, 10.1006/jsre.2001.6086 Leclercq, 2003, Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury, Gastroenterology, 124, 1451, 10.1016/S0016-5085(03)00270-1 Wustefeld, 2000, Hyperstimulation with interleukin-6 inhibits cell cycle progression after hepatectomy in mice, Hepatology, 32, 514, 10.1053/jhep.2000.16604 Veldhuis, 1996, Potential use of recombinant human interleukin-6 in clinical oncology, Leuk Lymphoma, 20, 673, 10.3109/10428199609052418 Tate, 2001, Phase I trial of simultaneous administration of GM-CSF and IL-6 in patients with renal cell carcinoma: clinical and laboratory effects, Ann Oncol, 12, 655, 10.1023/A:1011123432765